Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2005 Sep 19;77(3):331–336. doi: 10.1002/jmv.20460

False positive antibody results against human T‐cell lymphotropic virus in patients with severe acute respiratory syndrome

Kuo‐Chien Tsao 1,2, Guang‐Wu Chen 3, Chung‐Guei Huang 1,2, Ya‐Ling Huang 1,2, Jing‐Yi Lin 1, Mok‐Chee Keng 1,2, Chien‐Fen Sun 1,2, Shin‐Ru Shih 1,2,✉
PMCID: PMC7166782  PMID: 16173022

Abstract

Taiwan suffered from the outbreak of severe acute respiratory syndrome (SARS) in 2003. Our laboratory performed a series of virology and serology tests for SARS patients admitted to our hospital. Cross‐reactivity was found when testing for antibody against human T‐cell lymphotropic virus (HTLV) in one patient with SARS. Therefore, antibodies against HTLV were examined in paired‐sera from 26 SARS patients. ELISA and a neutralization test were used to measure anti‐SARS antibodies. Seroconversion for antibody against SARS‐CoV was observed in all patients. Surprisingly, with the use of ELISA for HTLV, sera for 13 patients were positive for HTLV (50%), and seroconversion for HTLV was also observed in 10 patients (38.5%). Western blot for HTLV on those 26 paired‐sera from 13 HTLV‐positive patients displayed 5 positive results for HTLV‐I, 7 positive results for HTLV‐II, 1 positive result for both HTLV‐I and II, 9 negative results for either HTLV‐I or HTLV‐II, and 4 “indeterminate” results. The findings that antibody to HTLV can be detected in blood samples collected from SARS patients provide important information for safe handling of blood products. Without such knowledge, blood products can be discarded mistakenly even though they contain anti‐SARS‐CoV antibodies that may be potentially valuable for SARS therapy. J. Med. Virol. 77:331–336, 2005. © 2005 Wiley‐Liss, inc.

Keywords: severe acute respiratory syndrome (SARS), human T‐cell lymphotropic virus (HTLV), cross‐reactivity

REFERENCES

  1. Chan KH, Poon LL, Cheng VC, Guan Y, Hung IF, Kong J, Yam LY, Seto WH, Yuen KY, Peiris JS. 2004. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis 10: 294–299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348: 1967–1976. [DOI] [PubMed] [Google Scholar]
  3. Hayes CG, Burans JP, Oberst RB. 1991. Antibodies to human T lymphotropic virus type I in a population from the Philippines: Evidence for cross‐reactivity with plasmodium falciparum. J Infect Dis 163: 257–262. [DOI] [PubMed] [Google Scholar]
  4. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, DeRisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348: 1953–1966. [DOI] [PubMed] [Google Scholar]
  5. Lu SC, Chen BH, Ling FW, Fen KS, Cheng HS, Tsung LW, Cheng KT. 2003. Seroindeterminate HTLV‐I prevalence and characteristics in blood donors in Taiwan. Trans Taiwan Soc Blood Transfusion 10: 186–187. [Google Scholar]
  6. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY. 2003a. Clinical progression and viral load in a community outbreak of coronavirus‐associated SARS pneumonia: A prospective study. Lancet 361: 1767–1772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY. 2003b. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361: 1319–1325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, Tellier R, Draker R, Adachi D, Ayers M, Chan AK, Skowronski DM, Salit I, Simor AE, Slutsky AS, Doyle PW, Krajden M, Petric M, Brunham RC, McGeer AJ. 2003. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 348: 1995–2005. [DOI] [PubMed] [Google Scholar]
  9. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen‐Rasmussen M, Fouchier R, Gunther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300: 1394–1399. [DOI] [PubMed] [Google Scholar]
  10. Rouet F, Meertens L, Courouble G, Herrmann‐Storck C, Pabingui R, Chancerel B, Abid A, Strobel M, Mauclere P, Gessain A. 2001. Serological, epidemiological, and molecular differences between human T‐cell lymphotropic virus Type 1 (HTLV‐1)‐seropositive healthy carriers and persons with HTLV‐I Gag indeterminate Western blot patterns from the Caribbean. J Clin Microbiol 39: 1247–1253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. WHO . 2003a. Case definitions for surveillance of severe acute respiratory syndrome (SARS) ULT: http://www.who.int/csr/sars/casedefinition/en/.
  12. WHO . 2003b. Severe acute respiratory syndrome (SARS): Laboratory diagnostic test ULT: http://www.who.int/csr/sars/diagnostictests/en/.
  13. Wu HS, Chiu SC, Tseng TC, Lin SF, Lin JH, Hsu YH, Wang MC, Lin TL, Yang WZ, Ferng TL, Huang KH, Hsu LC, Lee LL, Yang JY, Chen HY, Su SP, Yang SY, Lin SY, Lin TH, Su IS. 2004. Serologic and molecular biologic methods for SARS‐associated coronavirus infection, Taiwan. Emerg Infect Dis 10: 304–310. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Virology are provided here courtesy of Wiley

RESOURCES